These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 16370248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based, case-control study.
    Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J.
    Am J Obstet Gynecol; 2001 May; 184(6):1289-96. PubMed ID: 11349204
    [Abstract] [Full Text] [Related]

  • 3. Prevention of congenital abnormalities by vitamin A.
    Czeizel AE, Rockenbauer M.
    Int J Vitam Nutr Res; 1998 May; 68(4):219-31. PubMed ID: 9706496
    [Abstract] [Full Text] [Related]

  • 4. No teratogenic effect of prenoxdiazine: a population-based case-control study.
    Bártfai Z, Somoskövi A, Puhó EH, Czeizel AE.
    Congenit Anom (Kyoto); 2007 Mar; 47(1):16-21. PubMed ID: 17300686
    [Abstract] [Full Text] [Related]

  • 5. A population-based case-control study of the safety of oral anti-tuberculosis drug treatment during pregnancy.
    Czeizel AE, Rockenbauer M, Olsen J, Sørensen HT.
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):564-8. PubMed ID: 11409585
    [Abstract] [Full Text] [Related]

  • 6. Senna treatment in pregnant women and congenital abnormalities in their offspring--a population-based case-control study.
    Acs N, Bánhidy F, Puhó EH, Czeizel AE.
    Reprod Toxicol; 2009 Jul; 28(1):100-4. PubMed ID: 19491001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Attempt with oral immunobiotherapy (broncho-vaxom) and immunochemotherapy (broncho-vaxom + neomycin) for the elimination of bacteria in symptom-free "other Salmonella" carriers.
    Münnich D, Dalmi L.
    Ther Hung; 1989 Jul; 37(4):209-15. PubMed ID: 2631289
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Maternal severe migraine and risk of congenital limb deficiencies.
    Bánhidy F, Acs N, Horváth-Puhó E, Czeizel AE.
    Birth Defects Res A Clin Mol Teratol; 2006 Aug; 76(8):592-601. PubMed ID: 16955495
    [Abstract] [Full Text] [Related]

  • 16. A population-based case-control teratologic study of ampicillin treatment during pregnancy.
    Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J.
    Am J Obstet Gynecol; 2001 Jul; 185(1):140-7. PubMed ID: 11483918
    [Abstract] [Full Text] [Related]

  • 17. Population-based case-control study of oxoline acid use during pregnancy for birth outcomes.
    Dudás I, Puhó E, Czeizel AE.
    Congenit Anom (Kyoto); 2006 Mar; 46(1):39-42. PubMed ID: 16643598
    [Abstract] [Full Text] [Related]

  • 18. Population-based case-control teratogenic study of hydroxyprogesterone treatment during pregnancy.
    Dudás I, Gidai J, Czeizel AE.
    Congenit Anom (Kyoto); 2006 Dec; 46(4):194-8. PubMed ID: 17096820
    [Abstract] [Full Text] [Related]

  • 19. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study.
    Nørgård B, Puho E, Pedersen L, Czeizel AE, Sørensen HT.
    Am J Gastroenterol; 2003 Sep; 98(9):2006-10. PubMed ID: 14499779
    [Abstract] [Full Text] [Related]

  • 20. Is there a reduction of congenital abnormalities in the offspring of diabetic pregnant women after folic acid supplementation? A population-based case-control study.
    Bánhidy F, Dakhlaoui A, Puhó EH, Czeizel AA.
    Congenit Anom (Kyoto); 2011 Jun; 51(2):80-6. PubMed ID: 21039913
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.